Zabke C, Dietze S, Stamer K, et al. (2008) Early and advanced stages of Tau aggregation in transgenic mouse models. Alzheimers Dement 4:T221-T222.

Staff RT, Ahearn TS, Murray AD, et al. (2008) Tau aggregation inhibitor (TAI) therapy with remberTM arrests the trajectory of rCBF decline in brain regions affected by Tau pathology in mild and moderate Alzheimer's disease (AD). Alzheimers Dement 4:T775.

Murray AD, Staff RT, Ahearn TS, et al. (2008) Tau Aggregation Inhibitor (TAI) therapy with remberTM changes glucose metabolism in the medial temporal lobes in mild and moderate Alzheimer's disease (AD). Alzheimers Dement 4:T786.

Melis V, Deiana S, Zabke C, et al. (2008) Reversal of spatial problem-solving cognitive deficit in a transgenic mouse line overexpressing the repeat domain of Tau by treatment with the Tau aggregation inhibitor methylthioninium chloride. Alzheimers Dement 4:T485.

Deiana S, Harrington C, Riedel G, et al. (2008) Methylthioninium chloride versus rivastigmine and their co-administration efficacy in reversing scopolamine-induced cognitive deficits in a pharmacological mouse model of Alzheimer's disease. Alzheimers Dement 4:T499.